07 Jan 2001

Amineurin® 10 (Amineurin® 10/-25/-50 Filmtabletten) - Deutschland

Updated: 07 Jan 2001

Amineurin® 10 | -25 | -50; 25 retard | -50 retard | -75 retard; -100 retard

Depressive Erkr. insbes. vom ängstlich-agitierten Typ. Amineurin 100 retard zusätzl.: langfristige Schmerzbehandl. im Rahmen eines therapeut. Gesamtkonzeptes.

Amineurin® 10 Description, Presentation and Dosage

Amineurin® 10 Description

Amineurin® 10 Drug Class Description

Einzelstoffe

Amineurin® 10 Drug Description

1 Filmtbl. enth.: Amitriptylin-HCl 11,32 mg/28,3 mg/56,6 mg (entspr. 10 mg/25 mg/50 mg Amitriptylin).

Amineurin® 10 Generic Name

Amineurin® 10/-25/-50 Filmtabletten

Amineurin® 10 Presentation

Amineurin® 10 Presentation

Amineurin® 10/-25/-50; 25 retard/-50 retard/-75 retard; -100 retard

Amineurin® 10 Manufacturer

Hexal/Neuro Hexal

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Amineurin® 10 Dosage

Amineurin® 10 Adult Dosage

Calciumhydrogenphosphat, Hypromellose, Lactose, Magnesiumstearat, Macrogol 4000, Maisstärke, Poly(O-carboxymethyl)stärke, Natrium, Siliciumdioxid, Farbstoff E 171, Amineurin 10 zusätzlich: Farbstoff E 132, Amineurin 25 zusätzlich: Farbstoff E 172, Amineurin 50 zusätzl.: Cellulose, Povidon, Farbstoff E 172. E 131, 50/-75 retard zusätzlich: Farbstoff E 132. E 171.

Amineurin® 10 Child Dosage


Amineurin® 25 retard/-50 retard/-75 retard Retardkapseln
Zus.: 1 Retardkps. enth.: Amitriptylin-HCl 25 mg/50 mg/75 mg.
Weit. Bestandteile: Gelatine, Maisstärke, Povidon, Saccharose, Schellack, Talkum, Farbstoffe E 127, E 171, E 172, 25 retard zusätzlich: Farbstoff

Amineurin® 100 retard Retardtabletten
Zus.: 1 Retardtbl. enth.: Amitriptylin-HCl 100 mg.
Weit. Bestandteile: Cellulose, Hydroxypropylcellulose, Hypromellose, Lactose, Macrogol 4000, Magnesiumstearat, Natriumalginat, Siliciumdioxid, Farbstoffe E 104, E 132,

Amineurin® 10 Precautions, Reactions and Contraindications

Amineurin® 10 Special Precautions

Amineurin® 10 Special Precautions

T 60 b-d. Akutes Harnverhalten, Pylorusstenose, paralytischer Ileus, Vergrößerung d. Prostata mit Restharnbildung.

Amineurin® 10 Adverse Reactions

Amineurin® 10 Adverse Reactions

T 60

Related Drugs - Psychiatry/Mental Health

Back to top